-
-
-
-
-
-
-
Tango Therapeutics Inc. (TNGX) PT Raised to $30 at Mizuho
-
-
-
-
-
-
-
Stifel on Tango Therapeutics Inc. (TNGX): 'We have been consistently bullish'
-
-
-
-
-
-
-
Tango Therapeutics Inc. (TNGX) PT Raised to $18 at Jefferies
-
-
-
-
-
-
-
Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note
-
-
-
-
-
-
-
Tango Therapeutics Inc. (TNGX) PT Raised to $15 at Wedbush
-
-
-
-
-
-
-
Tango Therapeutics, Inc (TNGX) Announces First Patient Dosed in TNG456 Phase 1/2 Trial in Patients With MTAP-deleted Glioblastomas and Other Solid Tumors
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Tango Therapeutics Inc. (TNGX)
-
416,808 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

